Swasthya, an integrated chronic condition management programme for families of patients with hypertension and diabetes mellitus: a study protocol for a randomised controlled trial.

Keywords : ['integrated chronic condition management programme', 'randomise control trial', 'study protocol', 'diabete mellitus', 'swasthya', 'patient', 'hypertension', 'family']
Author : Fist_Author_Year_PM
4

Educational films for improving screening and self-management of gestational diabetes in India and Uganda (GUIDES): study protocol for a cluster-randomised controlled trial.

Keywords : ['uganda guide study protocol', 'clusterrandomise control trial', 'improve screening', 'gestational diabete', 'educational film', 'selfmanagement', 'india']
Author : Fist_Author_Year_PM
4

Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (MUCONAB trial): Results of an open-label randomized controlled trial.

Keywords : ['adjunctive nebulized amphotericin b muconab trial result', 'openlabel randomize control trial', 'pulmonary mucormycosis', 'treatment']
Author : Fist_Author_Year_PM
4

Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study.

Keywords : ['type diabetes mellitus', 'randomise control efficacy', 'dipeptidyl inhibitor saxagliptin', 'safety study', 'renal impairment', 'longterm treatment', 'patient']
Author : Fist_Author_Year_PM
4

Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial.

Keywords : ['randomized doubleblind placebocontrolle clinical trial', 'severe chronic plaquetype psoriasis', 'pioglitazone therapy', 'combination acitretin', 'safety', 'patient', 'moderate', 'efficacy']
Author : Fist_Author_Year_PM
4

Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial.

Keywords : ['type diabetes mellitus inadequately control', 'metformin alone longterm extension', 'randomise control trial', 'saxagliptin vs glipizide', 'addon therapy', 'patient']
Author : Fist_Author_Year_PM
4

Liraglutide as add-on to sodium-glucose co-transporter-2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA-ADD2SGLT2i, a 26-week, randomized, double-blind, placebo-controlled trial.

Keywords : ['randomize doubleblind placebocontrolle trial', 'inadequately control type diabete', 'sodiumglucose inhibitor', 'patient', 'liraglutide', 'addon']
Author : Fist_Author_Year_PM
4

Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add-on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA-PRIME).

Keywords : ['liraglutide versus oral antidiabetic drug', 'type diabete uncontrolle', 'randomize clinical trial', 'primary care liraprime', 'metformin alone', 'glycaemic control', 'addon therapy', 'patient', 'maintenance']
Author : Fist_Author_Year_PM
4

Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial.

Keywords : ['newly diagnose type diabete', 'mark hyperglycemia subgroup analysis', 'randomize clinical trial', 'oral glucose lower', 'metformin compare', 'initial treatment', 'asian patient', 'linagliptin alone', 'linagliptin']
Author : Fist_Author_Year_PM
4

Eicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetes mellitus patients: a double-blind randomised clinical trial.

Keywords : ['overweight type diabete mellitus patient', 'eicosapentaenoic acid improve insulin sensitivity', 'doubleblind randomise clinical trial', 'blood sugar']
Author : Fist_Author_Year_PM
4